SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-10 |
| Reported value | $187,882,190 |
| Positions | 75 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SPDR SERIES TRUST | XBI | ST STR SP BIOT | $90,202,500 | 570,000 |
| ISHARES TR | SGOV | 0-3 MTH TREASURY | $70,469,000 | 700,000 |
| ROYALTY PHARMA PLC | RPRX | SHS CLASS A | $616,770 | 11,000 |
| NURIX THERAPEUTICS INC | NRIX | COM | $606,500 | 25,000 |
| INCYTE CORP | INCY | COM | $600,808 | 5,300 |
| ARGENX SE | ARGX | SPONSORED ADR | $594,701 | 641 |
| DISC MEDICINE INC | IRON | COM | $585,120 | 8,000 |
| RAPPORT THERAPEUTICS INC | RAPP | COM | $583,380 | 14,000 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | COM | $567,630 | 17,000 |
| TREVI THERAPEUTICS INC | TRVI | COM | $559,500 | 30,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.